![David Meek](https://cdn.zonebourse.com/static/resize/768/576/https://zonebourse.com/images/barons/david_meek_biographie.jpg)
David Meek
Vorsitzender bei ENTASIS THERAPEUTICS HOLDINGS INC.
Vermögen: 60 296 $ am 31.05.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Heather Elizabeth Preston | M | 58 | 7 Jahre | |
Heather Behanna | M | 49 |
Entasis Therapeutics, Inc.
![]() Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | 7 Jahre |
Jacques Suzanne | F | 53 | 7 Jahre | |
Nadim Ahmed | M | 56 | 3 Jahre | |
Matt Kapusta | M | 51 | 9 Jahre | |
Jacquelyn Sumer | F | 46 | 2 Jahre | |
Anthony Adam Rosenberg | M | 71 | 7 Jahre | |
Manoussos Perros | M | 56 | 9 Jahre | |
Christian Klemt | M | 51 | 9 Jahre | |
Margaret Liu | M | 67 | 7 Jahre | |
Robert Gut | M | 59 | 6 Jahre | |
Paula Soteropoulos | F | 56 | 11 Jahre | |
Jeannette Potts | M | 62 | - | |
Richard Porter | M | - | 3 Jahre | |
Jennifer Michaelson | M | 57 | 6 Jahre | |
Anne-Marie Martin | M | 52 | 2 Jahre | |
David Altarac | M | 63 |
Entasis Therapeutics, Inc.
![]() Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | 5 Jahre |
David Ryan | M | 57 | 2 Jahre | |
Madhavan Balachandran | M | 73 | 7 Jahre | |
Jack Kaye | M | 80 | 8 Jahre | |
Piet Wigerinck | M | 58 | 6 Jahre | |
Jeremy Springhorn | M | 61 | 7 Jahre | |
David Hastings | M | 62 | 6 Jahre | |
Leonard Post | M | 72 | 4 Jahre | |
Thomas Ebeling | M | 65 | 7 Jahre | |
Maria E. Cantor | F | 56 | 8 Jahre | |
Stephen Webster | M | 63 | 4 Jahre | |
Rose Weldon | F | - | 2 Jahre | |
Terrell B. Jones | M | 75 |
Camping & Education Foundation
| - |
Jeffrey Jones | M | 53 | 2 Jahre | |
Pierre Caloz | M | 52 | 3 Jahre | |
Erin Boyer | F | - | 2 Jahre | |
Matthew Ronsheim | M | 52 | 4 Jahre | |
Pavel Raifeld | M | 40 | 2 Jahre | |
Aidan Murphy | M | 58 | 6 Jahre | |
Corinne Savill | M | 64 | 7 Jahre | |
Kevin Johnston | M | - | 2 Jahre | |
Chad Messer | M | - | 2 Jahre | |
Anna Diaz Triola | F | - | 3 Jahre | |
R. Douglas Rose | M | 55 |
Camping & Education Foundation
| - |
Walid Abi-Saab | M | 59 | 1 Jahre | |
John Mueller | M | 64 | 9 Jahre | |
Ruben Tommasi | M | 58 | 9 Jahre | |
Stephen Andre | M | 62 | 2 Jahre | |
Regis Mulot | M | 58 | 6 Jahre | |
Marianne Zhen | F | 55 | 2 Jahre | |
Kyle Dow | M | - | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Sander J. van Deventer | M | 69 | 22 Jahre | |
Philip Astley-Sparke | M | 51 | 8 Jahre | |
Ludwig Hantson | M | 61 | 1 Jahre | |
John Valliant | M | 54 | 10 Jahre | |
Robert Hombach | M | 58 | 1 Jahre | |
Jorge Gallardo Ballart | M | 82 |
European Federation of Pharmaceutical Industries & Assns
![]() European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | 52 Jahre |
David Schaffer | M | 53 | 6 Jahre | |
Howard Mayer | M | 61 | 4 Jahre | |
Nicholas G. Galakatos | M | 66 | 4 Jahre | |
Vickie Reed | F | 62 | 9 Jahre | |
Ricardo Dolmetsch | M | 55 | 3 Jahre | |
Carol Stuckley | F | 68 | 4 Jahre | |
Aaron Ondrey | M | 48 | 2 Jahre | |
Kristie Wagner | F | 57 | - | |
Karen Ferrante | M | 66 | 1 Jahre | |
Alex Kuta | M | 64 | 6 Jahre | |
Philina Lee | M | 47 | 3 Jahre | |
Hélène Auriol-Potier | F | 61 | 4 Jahre | |
Scot Harper | M | 67 | 3 Jahre | |
Sotirios G. Stergiopoulos | M | 52 | 3 Jahre | |
Donald Bergstrom | M | 52 | 3 Jahre | |
Stephanie Dorn Miller | F | 50 | 1 Jahre | |
Eva M. Mulder | F | - | 5 Jahre | |
Robin Isaacs | M | 65 |
Entasis Therapeutics, Inc.
![]() Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | 4 Jahre |
Janice Murray | F | 58 |
Novartis Pharmaceuticals Canada, Inc.
![]() Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | 13 Jahre |
Temre Johnson | M | - | 5 Jahre | |
Daniel Faga | M | 44 | 1 Jahre | |
Pablo Cagnoni | M | 60 | 5 Jahre | |
Eric W. Kimble | M | 58 |
Entasis Therapeutics, Inc.
![]() Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | 1 Jahre |
Albert P. L. Stroucken | M | 76 | 1 Jahre | |
John D. Forsyth | M | 76 | 1 Jahre | |
Paul Sekhri | M | 66 | 5 Jahre | |
Blake E. Devitt | M | 77 | 1 Jahre | |
Carol Gallagher | M | 59 | 1 Jahre | |
Francois Nader | M | 67 | 1 Jahre | |
Barbara Duncan | F | 59 | 4 Jahre | |
Lesley Russell | M | 63 | 5 Jahre | |
Christophe Jean | M | 67 | 16 Jahre | |
Gail Fosler | F | 76 | 1 Jahre | |
Colin Goddard | M | 64 | 5 Jahre | |
Hervé Couffin | M | 72 | 13 Jahre | |
Douglas Bailey | M | 73 | 12 Jahre | |
Henry Fuchs | M | 66 | 11 Jahre | |
James R. Gavin | M | 78 | 1 Jahre | |
Pierre Martinet | M | 74 | 13 Jahre | |
Chau Khuong | M | 48 | 4 Jahre | |
Mike Gutch | M | 58 | 5 Jahre | |
Johan Rutger Christenson | M | 65 | 6 Jahre | |
Steven Gannon | M | 62 | 4 Jahre | |
Michael Seckler | M | 59 |
FerGene, Inc.
![]() FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | 3 Jahre |
Sonia Benhamida | M | - | 7 Jahre | |
Kathy Bodley | F | - | - | |
John Crowley | M | 51 | 5 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 57 | 57,00% |
Niederlande | 22 | 22,00% |
Frankreich | 13 | 13,00% |
Kanada | 11 | 11,00% |
Belgien | 1 | 1,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- David Meek
- Persönliches Netzwerk